Fintel reports that on July 25, 2025, Baird downgraded their outlook for Oscar Health (NYSE:OSCR) from Outperform to Neutral.

In this piece, we’ll check in on two mid-cap health insurance plays that are leveraging their tech-savvy and digital ...

Oscar Health Inc. slashed its outlook and reported preliminary results below Wall Street estimates, the latest health insurer ...

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today certain ...

Ahead of the company’s second-quarter earnings call Aug. 6, Oscar Health is slashing its full-year guidance by about half a ...

Oscar Health (NYSE:OSCR) stock fell 3.5% after the healthcare technology company revised its 2025 financial guidance following a review of second quarter Marketplace data that revealed ...

The health insurance agency said Tuesday it now expects a medical loss ratio of 86% to 87% for the full year, with total revenue now seen at $12 billion to $12.2 billion and a loss from operations of ...

Oscar Health (OSCR) shares rose 7% premarket on Tuesday after the company revised its full-year sales outlook.

Investing.com -- Oscar Health has increased its full-year revenue forecast to between $12 billion and $12.2 billion, up from its previous guidance of $11.20 billion to $11.30 billion. This new outlook ...

Creator Julian Fellowes, who also is behind “Downton Abbey,” loves nothing more than to devastate fans with a brutal death when they least expect it.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

In the latest trading session, Oscar Health, Inc. (OSCR) closed at $14.45, marking a +1.76% move from the previous day. This change outpaced the S&P 500's 0.4% gain on the day. Meanwhile, the Dow ...